Google
PRGO 株価分析 — PERRIGO COMPANY PLC (Healthcare >> Drug Manufacturers - Specialty & Generic)
PRGO に関するよくある質問
PRGOのPER（株価収益率）は？
PERRIGO COMPANY PLC（PRGO）は現在PER 203.80倍で取引されています。
PRGOのROE（自己資本利益率）は？
PERRIGO COMPANY PLCのROEは-72.74%です。
PRGOの配当利回りは？
PERRIGO COMPANY PLCの配当利回りは11.12%です。
PRGOの品質スコア（Quality Score）は？
当社のAIはPRGOの総合財務品質を100点中31点と評価しています。収益性・成長性・負債・利益の安定性に基づく評価です。
PRGOは今が買い時ですか？
当社AIのタイミングスコアは100点中27点で、テクニカル指標とモメンタムから見た現在価格の相対的な魅力度を示します。
PRGOはどのセクターに属しますか？
PERRIGO COMPANY PLCはHealthcare >> Drug Manufacturers - Specialty & Genericセクターに分類されます（NYSE市場）
PRGO AI Analysis Summary
Our AI summary for PRGO: PERRIGO COMPANY PLC (NYSE), Healthcare >> Drug Manufacturers - Specialty & Generic sector. The stock currently trades at a P/E of 203.80, ROE of -72.74%, a dividend yield of 11.12%. Its financial Quality Score stands at 31/100 — fundamentals below the market average. The AI Timing Score is 27/100 — most technical signals do not support an entry at this point. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.
|
USD 10.11
Price
-0.20
(-1.94%)
Day Change
|
|
|---|
PRGO, ファンダメンタルスコアはnot good ( ファンダメンタル = 31) そして テクニカルスコアは ...(Sign In to See)...
Loading chart...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
P/Eが高い。割高銘柄。
ROEが低い
ROAが低い
平均ROEが低い
昨年度のROEが一昨年比で低い
ROEが昨年度比で低い
Last-year ROA is lower than last-2-years ROA.
昨年度のROAが一昨年比で低い
NPMが低い
NPMの伸びが低い
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Momentum indicators aligned on the daily timeframe
In details, quality factors are not quite good , financial health is not good , and ability to make profit is ok , ...
| Deepscope 分析 |
|
50% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 93 |
| Magic Formula Rank by ROA |
N/A
|
| Magic Formula Rank by ROE |
N/A
|
| Magic Formula Rank by ROIC |
N/A
|
| Price | 10.11 |
| PBV / Sector |
0.57 / 3.22
GREAT
|
| Earning Per Share | -12.88 |
| PE / Sector |
203.80 / 29.79
|
| PEG or PE/Growth / Sector |
0.33 / 0.13
GOOD
|
| Average 1M Daily Value |
26.32 M
GREAT
|
| Average 1W Daily Value |
25.98 M
GREAT
|
| Timing Factors |
|
28% |
| Financial Health |
|
41% |
| ポイントになる統計 |
|
62% |
| 配当 |
|
100% |
| 登録情報 |
| Analyze Date | 2026-08-01 08:00:21 |
| Symbol | PRGO |
| Name | PERRIGO COMPANY PLC |
| Sector | Healthcare >> Drug Manufacturers - Specialty & Generic |
| Market | NYSE |
| Listed Shares | 138.37 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 1,426.57 / 10,754.62 |
| ニュース |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: The Sharp Building, Dublin, Ireland, D02 TY74
Phone: 353 1 709 4000
Website: https://www.perrigo.com
Employees: 8,100
Sector: Healthcare >> Drug Manufacturers - Specialty & Generic
Description: Perrigo Company plc provides over-the-counter health and wellness solutions in the United States, Europe, and internationally. The company operates through Consumer Self-Care Americas and Consumer Self-Care International segments. It offers upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and oral electrolyte beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers. The company also offers healthy lifestyle products, such as smoking cessation and well-being products; skin care products consisting of dermatological care, scar management, lice treatment, and other products for various skin conditions; women's health products comprising feminine hygiene and contraceptives; vitamins, minerals, and supplements; and other miscellaneous self-care products. It sells its products under the Compeed, Dr. Fresh, Firefly, Good Sense, Good Start, Mederma, Nasonex, Plackers, Prevacid24HR, REACH, Rembrandt, Steripod, Opill, Solpadeine, Coldrex, Physiomer, NiQuitin, ACO, ellaOne, and Compeed brands. The company also offers contract manufacturing services. It sells its products through retail drug, supermarket, and mass merchandise chains; e-commerce stores; wholesalers; pharmacies; drug and grocery retailers; and para-pharmacies. The company was formerly known as Perrigo Company and changed its name to Perrigo Company plc in December 2013. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.
Analyst Ratings & Target Price
ME vs SECTOR Healthcare >> Drug Manufacturers - Specialty & Generic
Click a bubble to view stock details · Bubble size represents market capitalization share
